A Single Antiviral for a Triple Epidemic: is It possible?
- 29 July 2023
- journal article
- research article
- Published by Taylor & Francis in Future Virology
- Vol. 18 (10) , 633-642
Abstract
Aim: A triple epidemic of respiratory syncytial virus (RSV), SARS-CoV-2 and influenza variants is on the rise worldwide. It is crucial to identify antiviral agents that can be used against all thre...Keywords
This publication has 28 references indexed in Scilit:
- Structure of the RNA-dependent RNA polymerase from COVID-19 virusScience, 2020
- RMSD and SymmetryJournal of Computational Chemistry, 2019
- CASTp 3.0: computed atlas of surface topography of proteinsNucleic Acids Research, 2018
- NMRbox: A Resource for Biomolecular NMR ComputationBiophysical Journal, 2017
- Molecular mechanism of respiratory syncytial virus fusion inhibitorsNature Chemical Biology, 2015
- Analyzing the interaction of a herbal compound Andrographolide from Andrographis paniculata as a folklore against swine flu (H1N1)Asian Pacific Journal of Tropical Disease, 2014
- High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activityProceedings of the National Academy of Sciences, 2010
- Structural insight into the essential PB1–PB2 subunit contact of the influenza virus RNA polymeraseThe EMBO Journal, 2009
- Binding Estimation after Refinement, a New Automated Procedure for the Refinement and Rescoring of Docked Ligands in Virtual ScreeningChemical Biology & Drug Design, 2009
- Molecular dynamics with coupling to an external bathThe Journal of Chemical Physics, 1984